Corcept Therapeutics
CORT
CORT
222 hedge funds and large institutions have $1.22B invested in Corcept Therapeutics in 2018 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 79 increasing their positions, 68 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.58% more ownership
Funds ownership: 77.22% → 78.8% (+1.6%)
3% less capital invested
Capital invested by funds: $1.26B → $1.22B (-$41M)
38% less call options, than puts
Call options by funds: $6.78M | Put options by funds: $10.9M
Holders
222
Holding in Top 10
3
Calls
$6.78M
Puts
$10.9M
Top Buyers
| 1 | +$15.7M | |
| 2 | +$8.18M | |
| 3 | +$6.1M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$6.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.5M |
Top Sellers
| 1 | -$16.3M | |
| 2 | -$7.96M | |
| 3 | -$7.58M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$6.48M |
| 5 |
Morgan Stanley
New York
|
-$4.92M |